06 April 2023

Two young researchers at the Faculty of Medicine and Health Sciences at LiU have been invited to participate in the Lindau Nobel Laureate Meetings in June 2023. Lotta Velin and Damon Frampton are looking forward to meeting 40 Nobel laureates and over 600 young researchers from all over the world.

Two portraits next to each other. One on a woman named Lotta and one on a man named Damon.
The two PhD students, Lotta Velin and Damon Frampton, will participate in an international research meeting in Germany, the Lindau Nobel Laureate Meeting.

Both PhD students are pursuing their research and doctoral studies at the Faculty of Medicine and Health Sciences and the Department of Biomedical and Clinical Sciences (BKV) at LiU. One is Damon Frampton, PhD student in Sara Liin's research group. He does research on ion channels and electrophysiology. The other is Lotta Velin, PhD student at the Center for Disaster Medicine and Traumatology (KMC). She does research in global health.

During the Lindau Nobel Laureate Meetings, to which they have been invited, the young LiU researchers get the chance to listen to lectures, Agora Talks, panel discussions as well as enjoy personal exchange for a few days with the Nobel Laureates and the other young scientists in physiology/medicine.

“I have often had the privilege of working with young researchers from other countries and always find it very inspiring and developing to be able to exchange ideas and perspectives with young colleagues. Many young researchers I have met have incredible drive and commitment, which I think gives me so much energy and motivates me further”, says Lotta Velin.

Damon Frampton is also looking forward to the event in June.

“I am extremely honored and grateful to have received the trust from Ragnar Söderberg's Foundation, who have both nominated me and supported my participation at the meeting in Lindau financially. Something I'm really looking forward to is the exposure to new perspectives on science and research, both from Nobel laureates but also from the 600 young researchers who have been invited to the meeting”, says Damon.

What do you hope the event can lead to?

“Becoming part of their alumni network. It could lead to finding new collaboration partners. Research is so much more than knowing everything in one's own field, and I think it will help me in my career and my development as a person to be able to take part in other people's experiences and think laterally”, says Damon Frampton.

Lotta Velin is on the same track. As a junior researcher, she is currently trying to shape her own research path going forward.

“I believe and hope that the Lindau meeting will be an opportunity to be inspired by young colleagues and prominent researchers, whose paths to research have certainly looked different. Of course, it also feels incredibly exciting to have the chance to meet and learn from some of the most prominent thinkers of our time - and also to be able to do it in such a special and intimate environment as Lindau”, says Lotta in conclusion.

The Lindau Nobel Laureate Meetings have been held since 1951, promoting conversation and exchange between different generations, scientific disciplines, and cultures.

You can find more information about the event and the program on their website: https://www.lindau-nobel.org/

Latest news from LiU

Two men in a computer server hall.

International collaboration lays the foundation for AI for materials

AI is accelerating the development of new materials. Large-scale use and exchange of data on materials is facilitated by a broad international standard. A major international collaboration now presents an extended version of the OPTIMADE standard.

Female PhD student lectures to master's students in the lab.

From sketches to a robot with artificial intelligence

How do you develop a product with as little human involvement as possible? LiU students built a robot using generative artificial intelligence.

Iontronic pump in thin blood vessels.

More effective cancer treatment with iontronic pump

When low doses of cancer drugs are administered continuously near malignant brain tumours using so-called iontronic technology, cancer cell growth drastically decreases. This is demonstrated in experiments with bird embryos.